Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma

Gynecologic Oncology

Volumn 60, Issue 3, 1996, Pages 363-372

  Srivatsa, Preeti J ^a   Cliby, William A ^a   Keeney, Gary L ^a   Dodson, Mark K ^a   Suman, Vera J ^a   Roche, Patrick C ^a   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; NUCLEOSIDE DIPHOSPHATE KINASE; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CYTODIAGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE COURSE; EPITHELIUM TUMOR; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

EID: 0029984629     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0056     Document Type: Article

References (37)

1. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics, 1994, CA Cancer J. Clin. 44, 7-26 (1994).
2. Omura, G. A., Brady, M. F., Homesley, H. D., Yordan, E., Major, F. J., Buchsbaum, H. J., and Park, R. C. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience, J. Clin. Oncol. 9, 1138-1150 (1991).
3. Hartmann, L. C., Sebo, T. J., Kamel, N. A., Podratz, K. C., Cha, S. S., Wieand, H. S., Keeney, G. L., and Roche, P. C. Proliferating cell nuclear antigen in epithelial ovarian cancer: Relation to results at second-look laparotomy and survival, Gynecol. Oncol. 47, 191-195 (1992).
4. Steeg, P. S., Bevilacqua, G., Kopper, L., Thorgeirsson, U. P., Talmadge, J. E., Liotta, L. A., and Sobel, M. E. Evidence for a novel gene associated with low tumor metastatic potential, J. Natl. Cancer Inst. 80, 200-204 (1988).
5. Rosengard, A. M., Krutzsch, H. C., Shearn, A., Biggs, J. R., Barker, E., Margulies, I. M., King, C. R., Liotta, L. A., and Steeg, P. S. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development, Nature 342, 177-180 (1989).
6. Stahl, J. A., Leone, A., Rosengard, A. M., Porter, L., King, C. R., and Steeg, P. S. Identification of a second human nm23 gene, nm23-H2, Cancer Res. 51, 445-449 (1991).
7. Wallet, V., Mutzel, R., Troll, H., Barzu, O., Wurster, B., Veron, M., and Lacombe, M. L. Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development, J. Natl. Cancer Inst. 82, 1199-1202 (1990).
8. Steeg, P. S., de la Rosa, A., Flatow, U., MacDonald, N. J., Benedict, M., and Leone, A. Nm23 and breast cancer metastasis, Breast Cancer Res. Treat. 25, 175-187 (1993).
9. Sastre-Garau, X., Lacombe, M. L., Jouve, M., Veron, M., and Magdelenat, H. Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph-node metastasis, Int. J. Cancer 50, 533-538 (1992).
10. Bevilacqua, G., Sobel, M. E., Liotta, L. A., and Steeg, P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential, Cancer Res. 49, 5185-5190 (1989).
11. Barnes, R., Masood, S., Barker, E., Rosengard, A. M., Coggin, D. L., Crowell, T., King, C. R., Porter-Jordan, K., Wargotz, E. S., Liotta, L. A., and Steeg, P. S. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival, Am. J. Pathol 139, 245-250 (1991).
12. Hennessy, C., Henry, J. A., May, F. E., Westley, B. R., Angus, B., and Lennard, T. W. Expression of the antimetastatic gene nm23 in human breast cancer: An association with good prognosis, J. Natl. Cancer Inst. 83, 281-285 (1991).
13. Hirayama, R., Sawai, S., Takagi, Y., Mishima, Y., Kimura, N., Shimada, N., Esaki, Y., Kurashima, C., Utsuyama, M., and Hirokawa, K. Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer, J. Natl. Cancer Inst. 83, 1249-1250 (1991).
14. Royds, J. A., Stephenson, T. J., Rees, R. C., Shorthouse, A. J., and Silcocks, P. B. Nm23 protein expression in ductal in situ and invasive human breast carcinoma, J. Natl. Cancer Inst. 85, 727-731 (1993).
15. Steeg, P. S., Cohn, K. H., and Leone, A. Tumor metastasis and nm23: Current concepts, Cancer Cells 3, 257-262 (1991).
16. Nakayama, T., Ohtsuru, A., Nakao, K., Shima, M., Nakata, K., Watanabe, K., Ishii, N., Kimura, N., and Nagataki, S. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product, J. Natl. Cancer Inst. 84, 1349-1354 (1992).
17. Steeg, P. S., Bevilacqua, G., Sobel, M. E., and Liotta, L. A. Identification and characterization of differentially expressed genes in tumor metastasis: The nm23 gene, Basic Life Sci. 57, 355-360 (1991).
18. Florenes, V. A., Aamdal, S., Myklebost, O., Maelandsmo, G. M., Burland, O. S., and Fodstad, O. Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression, Cancer Res. 52, 6088-6091 (1992).
19. Hailat, N., Keim, D. R., Melhem, R. F., Zhu, X. X., Eckerskorn, C., Brodeur, G. M., Reynolds, C. P., Seeger, R. C., Lottspeich, F., Strahler, J. R., and Hanash, S. M. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification, J. Clin. Invest. 88, 341-345 (1991).
20. Leone, A., Seeger, R. C., Hong, C. M., Hu, Y. Y., Arboleda, M. J., Brodeur, G. M., Stram, D., Slamon, D. J., and Steeg, P. S. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas, Oncogene 8, 855-865 (1993).
21. Luo, W., Matsuo, K., Nagayama, Y., Urano, T., Furukawa, K., Takeshita, A., Nakayama, T., Yokoyama, N., Yamashita, S., Isumi, M., Shiku H., and Nagataki S. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: Lack of correlation between its expression and lymph node metastasis, Thyroid 3, 105-109 (1993).
22. Higashiyama, M., Doi, O., Yokouchi, H., Kodama, K., Nakamori, S., Tateishi, R., and Kimura, N. Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value, Br. J. Cancer 66, 533-536 (1992).
23. Arai, T., Watanabe, M., Onodera, M., Yamashita, T., Msunaga, A., Itoyama, S., Itoh, K., and Sugawara, I. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid, Am. J. Pathol. 142, 1938-1944 (1993).
24. Farley, D. R., Eberhardt, N. L., Grant, C. S., Schaid, D. J., van Heerden, J. A., Hay, I. D., and Khosla, S. Expression of a potential metastasis suppressor gene (nm23) in thyroid neoplasms, World J. Surg. 17, 615-620 (1993).
25. Igawa, M., Rukstalis, D. B., Tanabe, T., and Chodak, G. W. High levels of nm23 expression are related to cell proliferation in human prostate cancer, Cancer Res. 54, 1313-1318 (1994).
26. Nakamori, S., Ishikawa, O., Ohigashi, H., Imaoka, S., Sasaki, Y., Kameyama, M., Kabuto, T., Furukawa, H., Iwanakga, T., and Kimura, N. Clinicopathological features and prognostic significance of nucleoside diphosphate kinase/nm23 gene product in human pancreatic exocrine neoplasms, Int. J. Pancreatol. 14, 125-133 (1993).
27. Engel, M., Theisinger, B., Seib, T., Seitz, G., Huwer, H., Zang, K. D., Welter, C., and Dooley, S. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages, Int. J. Cancer 55, 375-379 (1993).
28. Mandai, M., Konishi, I., Koshiyama, M., Mori, T., Arao, S., Tashiro, H., Okamura, H., Nomura, H., Hiai, H., and Fukumoto, M. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: Correlation with clinicopathology, EGFR, c-erbB-2, and c-erB-3 genes, and sex steroid receptor expression, Cancer Res. 54, 1825-1830 (1994).
29. MacDonald, N. J., De La Rosa, A., Benedict, M. A., Freije, J. M., Krutsch, H., and Steeg, P. S. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential, J. Biol. Chem. 268, 25780-25789 (1993).
30. Lacombe, M. L., Sastre-Garau, X., Lascu, I., Vonica, A., Wallet, V., Thiery, J. P., and Veron, M. Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours, Eur. J. Cancer 27, 1302-1307 (1991).
31. Gilles, A. M., Presecan, E., Vonica, A., and Lascu, I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme, J. Biol. Chem. 266, 8784-8789 (1991).
32. Teng, D. H., Engele, C. M., and Venkatesh, T. R. A product of the prune locus of Drosophila is similar to mammalian GTPase-activating protein, Nature 353, 437-440 (1991).
33. Okabe-Kado, J., Kasukabe, T., Honma, Y., Hayashi, M., Henzel, W. J., and Hozumi, M. Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase, Biochem. Biophys. Res. Commun. 182, 987-994 (1992).
34. Dumas, C., Lascu, I., Morera, S., Glaser, P., Fourme, R., Wallet, V., Lacombe, M. L., Veron, M., and Janin, J. X-ray structure of nucleoside diphosphate kinase, EMBO J. 11, 3203-3208 (1992).
35. Ohtsuki, K., and Yokoyama, M. Direct activation of guanine nucleotide binding proteins through a high-energy phosphate-transfer by nucleoside diphosphate-kinase, Biochem. Biophys. Res. Commun. 148, 300-307 (1987).
36. Parks, R., and Agarwall, R. Nucleoside diphosphokinases, Academic Press, New York, pp. 307-334 (1973).
37. Wakefield, L. M., Thompson, N. L., Flanders, K. C., O'Connor-McCourt, M. D., and Sporn, M. B. Transforming growth factor-beta: Multifunctional regulator of cell growth and phenotype, Ann. N. Y. Acad. Sci. 551, 290-298 (1988).